Wednesday, June 10, 2026
πŸ‡ΊπŸ‡Έ FDA

pharma Β· Inflammatory Bowel Disease (IBD) Β· Melanoma Β· IRON

Disc Medicine

Disc Medicine clinical programs β€” 308 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON Β· NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
442
Patents
706
Official website β†— All projects Drug pipeline Patents News & analysis
Intelligence Β· Clinical Programs

Disc Medicine projects

308 ClinicalTrials.gov programs sponsored by Disc Medicine.

Disc Medicine has 308 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

308 programs

Clinical programs

Page 6 of 7

  1. Fentanyl hameln 50 microgram/ml for healthy volunteers, opioid use…

    Disc Medicine

    healthy volunteers, opioid use disorder

    approved small molecule active

    1 trial

  2. Ferinject

    Disc Medicine

    Patients with Aortic stenosis and Iron deficiency

    approved small molecule active

    1 trial

  3. Fluenz nasal spray suspension Influenza vacci... for Influenza

    Disc Medicine

    Influenza

    approved small molecule active

    1 trial

  4. Foliumzuur Aurobindo for Psoriatic arthritis

    Disc Medicine

    Psoriatic arthritis

    approved small molecule active

    1 trial

  5. IMATINIB for Chronic myeloid leukaemia

    Disc Medicine

    Chronic myeloid leukaemia

    approved small molecule active

    1 trial

  6. INDOCYANINE GREEN

    Disc Medicine

    cervical cancer stage I-IIA

    approved small molecule active

    1 trial

  7. INTENSIFY SZ

    Disc Medicine

    schizophrenia, schizoaffective disorder, schizophrenifom disorder

    approved small molecule active

    1 trial

  8. IRON OXIDE (E172)

    Disc Medicine

    Glioblastoma

    approved small molecule active

    1 trial

  9. Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Disc Medicine

    autoimmune disorders, joint disorders synonym: Still's disease, systemic JIA

    approved small molecule active

    1 trial

  10. LACTOSE MONOHYDRATE for (Chronic) Peripheral (occlusive) arterial disease (PAD)

    Disc Medicine

    (Chronic) Peripheral (occlusive) arterial disease (PAD)

    approved small molecule active

    1 trial

  11. MEPOLIZUMAB

    Disc Medicine

    Eosinophilic Granulomatosis with Polyangiitis (eGPA)

    approved small molecule active

    1 trial

  12. METHADONE for Opioid use disorder (DSM-5); ch…

    Disc Medicine

    Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).

    approved small molecule active

    1 trial

  13. MORPHINE for Prostate cancer

    Disc Medicine

    Prostate cancer

    approved small molecule active

    1 trial

  14. Myozyme 50 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease / glycogenosis type II / acid maltase deficiency

    approved small molecule active

    1 trial

  15. Myozyme powder for concentrate for solution f... for Pompe disease

    Disc Medicine

    Pompe disease

    approved small molecule active

    1 trial

  16. Mysimba 8 mg/90 mg prolonged-release tablets

    Disc Medicine

    Obesity, Obesity Surgery

    approved small molecule active

    1 trial

  17. NIVOLUMAB

    Disc Medicine

    Melanoma, Renal cell carcinoma

    approved small molecule active

    1 trial

  18. NL6220204217

    Disc Medicine

    HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.

    approved small molecule active

    1 trial

  19. NL65364.078.18

    Disc Medicine

    Strictures after esophageal atresia repair

    approved small molecule active

    1 trial

  20. NL71782.078.19

    Disc Medicine

    Pulmonary sarcoidosis

    approved small molecule active

    1 trial

  21. NL77315.078.21

    Disc Medicine

    Patients with coronary artery disease and an indication for PCI

    approved small molecule active

    1 trial

  22. NL77785.078.21

    Disc Medicine

    Complex regional pain syndrome

    approved small molecule active

    1 trial

  23. Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Glycogen storage disease type II or acid maltase deficiency, Pompe disease

    approved small molecule active

    1 trial

  24. OXALIPLATIN, CAPECITABINE

    Disc Medicine

    Locally advanced or metastatic gastro-intestinal carcinoma

    approved small molecule active

    1 trial

  25. P19.040

    Disc Medicine

    Migraine

    approved small molecule active

    1 trial

  26. PALEXIA Retard 50 mg tabletten met verlengde afgifte

    Disc Medicine

    chronic postoperative pain

    approved small molecule active

    1 trial

  27. PREDNISONE for kidney transplantation

    Disc Medicine

    kidney transplantation

    approved small molecule active

    1 trial

  28. PRIMERA001

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial

  29. PROGRAF capsule for pediatric kidney transplant recipients

    Disc Medicine

    pediatric kidney transplant recipients

    approved small molecule active

    1 trial

  30. PaNaMa 12782

    Disc Medicine

    Episodic expiratory wheezing

    approved small molecule active

    1 trial

  31. PaNaMa ID: 116348

    Disc Medicine

    Failure to wean from invasive ventilation.

    approved small molecule active

    1 trial

  32. PaNaMa code: 113071

    Disc Medicine

    Pulmonary Hypertension, Coronary Microvascular Dysfunction, Hypoxia, Heart Failure

    approved small molecule active

    1 trial

  33. Pioglitazone and Metformin

    Disc Medicine

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  34. Placebo of rosuvastatin (tablet) as produced...

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial

  35. Placebo used in this trial is a foodgrade for Autosomal Dominant Polycystic K…

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  36. Placebo: PL1 for Posttraumatic Stress Disorder (PTSD)

    Disc Medicine

    Posttraumatic Stress Disorder (PTSD)

    approved small molecule active

    1 trial

  37. Pneumovax 23 for Vaccination response

    Disc Medicine

    Vaccination response

    approved small molecule active

    1 trial

  38. Prednisolone Soluble Tablets for kidney transplant

    Disc Medicine

    kidney transplant

    approved small molecule active

    1 trial

  39. R0126321A

    Disc Medicine

    Diabetic foot ulcer

    approved small molecule active

    1 trial

  40. RIMEGEPANT , Capsaicin

    Disc Medicine

    Obesity, Migraine

    approved small molecule active

    1 trial

  41. ROPIVACAINE , SODIUM CHLORIDE

    Disc Medicine

    Urolithiasis

    approved small molecule active

    1 trial

  42. Rabipur for health volunteerst

    Disc Medicine

    health volunteerst

    approved small molecule active

    1 trial

  43. Radio-Flu 0 for Transthyretin amyloid cardiomyopathy

    Disc Medicine

    Transthyretin amyloid cardiomyopathy

    approved small molecule active

    1 trial

  44. Remsima 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Crohn's Disease

    approved small molecule active

    1 trial

  45. SALINE, TRANEXAMIC ACID

    Disc Medicine

    Slipped capital femoral epiphysis (SCFE), Legg-CalvΓ©-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)

    approved small molecule active

    1 trial

  46. SODIUM CHLORIDE, ROPIVACAINE HYDROCHLORIDE

    Disc Medicine

    Total Hip Arthroplasty / THA

    approved small molecule active

    1 trial

  47. Semaglutide B 3.0 mg/ml PDS290

    Disc Medicine

    obesity

    approved small molecule active

    1 trial

  48. Shexiang Baoxin pill（MUSKARDIAοΌ‰

    Disc Medicine

    Ischemia With Non-Obstructive Coronary Artery

    approved other completed

    1 trial

Frequently asked questions

How many clinical projects does Disc Medicine have?

308 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.